Successful Conclusion! The 27th CMTF Shenzhen Concludes Triumpantly！

Executive Highlights: Focusing on Practical Translation & Commercialization Pathways

From July 16 to 18, 2026, organized by Zhenghe Exhibition, The 27th Shenzhen International Medical Tourism Fair (CMTF), along with the 17th Cell Biology Industry Conference & Cell Therapy and Regenerative Medicine Conference, the 10th International Functional Medicine & Longevity Technology Innovation Conference, and the World Summit on Assisted Reproductive Technology, officially concluded at the Shenzhen Convention and Exhibition Center (Futian).

This three-day grand gathering convened over 250 international hospitals and premium health brands from around the globe, attracting more than 23,000 professional visitors. The exhibition floor buzzed with activity, witnessing continuous contract signings and high-level networking. By deeply integrating three core sectors—Medical Tourism, Functional Medicine, and Cell Biology—the joint events successfully fostered a new health industry ecosystem spanning "Prevention – Treatment – Rehabilitation – Wellness."

Three-In-One Synergy: Unlocking New Opportunities in a Trillion-Dollar Market

As one of China's most open and economically dynamic regions, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) boasts a permanent population of over 86 million and a GDP exceeding 14 trillion RMB. This massive population base and concentration of high-net-worth individuals (HNWIs) have fueled a surging demand for cross-border healthcare and long-term health management.

Hosting this edition in Shenzhen strategically leveraged both policy dividends—such as the "Hong Kong and Macao Medicine and Equipment Connect"—and natural cross-border advantages, creating an elite one-stop platform for global healthcare resources entering the GBA market.

The exhibition featured three major theme zones, covering full-life-cycle healthcare services and products:

1. International Medical Tourism & Assisted Reproduction Zone

Featured leading international hospitals and groups including Avenue Cell Clinic (CPC Corp.), Incinta Medical Group, Malaysia Healthcare Travel Council (MHTC)—leading KPJ Sabah Specialist Hospital, Alpha IVF & Women’s Specialists, Prince Court Medical Centre, Gleneagles Hospital Kuala Lumpur, KPJ Damansara Specialist Hospital, and Sunway Fertility Centre—Tang Reproductive Hospital (Kyrgyzstan), ANKH Function Regenerative Pain Health Group, Keyu Youdao (Thailand Sakura International Hospital), Royal REP Reproductive Hospital (Thailand), CGM Medical (Nanjing Guoming Yukang Clinic), Bumrungrad International Hospital, and Shenzhen Hospital of Southern Medical University.

• Scope: Cross-border medical travel, assisted reproduction (IVF/ART), precision physical examinations, oncology care, advanced pharmaceuticals, stem cells and regenerative medicine, international referrals, high-end commercial health insurance, anti-aging, and wellness management. It bridged regional and information gaps, catering to both outbound medical travel and inbound care to China.

2. Cell Biology & Regenerative Medicine Zone

Focused on cutting-edge technologies including immuno-oncology, stem cells, iPSCs, and exosomes. Exhibitors included BGI Cell, InxMed, SinoCells, Shanghai Cell Therapy Group, Xiankangda Biotech, Huixin Biomedical, CELUVIN, Aibihe Biotech, and VisiCure Biotech.

• Upstream Supply Chain Pioneers: Industry leaders like Haier Biomedical, Bairaikang Cell Pharma, Zhongying Biotech, Saipu Biotech, Luon Xinghan Life Sciences, Jingzhi Era Tech, and Carl Zeiss presented end-to-end solutions in cell culture, raw consumables, and biotech equipment, mapping the complete innovation chain from basic research to clinical translation.

3. Functional Medicine & Longevity Technology Zone

Featured innovative organizations including Yunzhijun Precision Medicine, Chengge Medical, Yeweita Group, Baimei Medical, Eagle-Eye Medical, Kangnuo Biotech, Jiruikang Biotech, Gaomei Genomics, Shenzhen Hengsheng Hospital Chronic Disease Integrative Medicine Center, Hailu Microecology Pharma, Junyou Medical, Guangxi Tech, Newber Anti-Aging, Huahe Shangyi, LifeClinic, Narixin, NADclinic, Singlera Genomics, Shantai Health, Sibo Regeneration, Bohou Health, Cyprus, Shenhu Zhikang, Xinyin Tech, Global Anti-Aging, Jiantuo, Baize Life, Dinasi, Jianghan Biotech, and Ankangda.

• Scope: Longevity medicine, gut microecology, fecal microbiota transplantation (FMT), anti-aging interventions, chronic disease management, precision nutritional conditioning, NAD+/NMN applications, cancer vaccines, methylation testing, pan-cancer early screening, chronic food allergy testing, functional diagnostics, hyperbaric oxygen chambers, and digital health management platforms.

100+ Keynote Presentations: A Knowledge Feast Driving Industry Insights

Concurrently, the event hosted nearly 100 high-spec professional forums across four dedicated conference rooms. Top scholars and clinical experts from China, Japan, the United States, Europe, and Southeast Asia delivered packed-house presentations:

• Cell Therapy & Regenerative Medicine: Key discussions centered on new immuno-oncology strategies, bottlenecks in NK cell translation, clinical pathways for stem cells under new regulations (Decree No. 818/828), iPSC tech breakthroughs, and exosome regulatory frameworks.

• Functional Medicine & Longevity Tech: Panels explored precision health, chronic disease reversal, metabolic syndrome interventions, clinical validation of NAD+, brain health management, and digital health twin platforms.

• Gut Microecology: Experts analyzed the clinical panorama of FMT, live biotherapeutic product (LBP) development, and the deep connection between immune microecology and chronic conditions.

• World Summit on Assisted Reproductive Technology (ART): Sessions highlighted PGT technology iterations, AI-driven decision-making, comprehensive solutions for advanced maternal age, and global venture capital trends in ART.

• Bay Area Synergy Summits (Conference Room 4): Attracted massive engagement covering Biomedical Talent Greater Bay Area Gathering, Insurance Investment Opportunities, Silver Economy Ecosystems, Healthy China Initiatives, Medical Aesthetics, International Education, Identity, and Asset Planning.

European Medical Center from Russia

LifeClinic from HongKong

Cross-Industry Integration: Opening a New Chapter for the Health Economy

Technological breakthroughs in cell biology (such as exosomes and stem cell regeneration) are injecting fresh clinical ideas into functional chronic disease management. Conversely, functional medicine's preventive philosophy elevates the full-cycle service model of medical tourism. Furthermore, the globalization of medical tourism accelerates cell technologies moving from the lab to clinics, while functional medicine's personalized protocols unlock consumer-grade markets for cell products.

The deep synthesis of these three theme exhibitions realized a seamless cross-industry bridge, accelerating the translation of innovative results and pushing the global healthcare industry toward higher, broader, and deeper dimensions.

Zhenghe Exhibition remains committed to building a dual-engine platform driven by "vertical expertise + cross-border integration." Following the successful conclusion of the Shenzhen event, the national tour continues!

📅 Upcoming Tour Destinations

• Hangzhou Stop: September 3–4, 2026 | Hangzhou International Conference Center

• Beijing Stop: November 19–21, 2026 | Beijing

We sincerely invite industry peers to join us in Hangzhou and Beijing to co-explore new horizons in the global longevity and medical economy!

• Exhibitor / Speaker Inquiries: +86-13570219945 (Phone & WeChat & Whatsapp)